Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-12

Clinical Trial Update: Immunotherapy Administered Under the Tongue to Treat Dust Mite Allergy [NA]

View source ↗

Summary

A completed clinical trial evaluating tongue-administered immunotherapy for asthma related to dust mite allergy; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Asthma | NA | Status: COMPLETED | Results posted: 2019-06-12